|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's range||26.39 - 28.62|
|52-week range||15.58 - 48.40|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
FRIENDSWOOD, Texas, February 01, 2023--Castle announced that it has received a 2023 Top Workplaces USA award from Energage.
FRIENDSWOOD, Texas, January 23, 2023--Castle's medical director, Matthew Goldberg, M.D., F.A.A.D., will present at the Precision Medicine World Conference (PMWC®) 2023 on Jan. 25.
FRIENDSWOOD, Texas, January 17, 2023--Castle is sharing new data supporting the clinical value of their skin cancer tests at the 2023 Winter Clinical Dermatology Conference - Hawaii®.